Cargando…
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
In recent years, advances in next-generation sequencing (NGS) technology have provided the opportunity to detect putative genetic drivers of disease, particularly cancers, with very high sensitivity. This knowledge has substantially improved our understanding of tumor pathogenesis. In hematological...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992944/ https://www.ncbi.nlm.nih.gov/pubmed/27597933 http://dx.doi.org/10.3389/fonc.2016.00187 |